Kourtney Kardashian’s new “GLP-1 Daily” pill is the latest product to capitalize on the weight loss drug craze.

Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...

Dr. Iris Gorfinkel joins us with the latest health headlines. From Health Canada’s approval of the new COVID vaccine and ...

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

Ozempic maker Novo Nordisk (NVO) announced mixed results today for a phase 2 trial of an experimental weight loss pill that ...

A new weight loss pill developed by the maker of Ozempic and Wegovy helped overweight and obese people lose up to 13% of ...

The future holds promise for robots to actively collaborate in diverse aspects of human endeavor, transforming industries ...

17. Semaglutide, the active ingredient in Ozempic, is being developed in pill form by Novo Nordisk and has shown promising results, with study participants losing an average of 15% of their body ...

Novo Nordisk (NVO) stock is falling Friday morning after the pharmaceutical giant shared that additional weight loss tied to ...

Kourtney Kardashian showcased her new signature product, which she describes as a "breakthrough innovation" in weight loss ...